Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 58 (-6.5%)Axles India₹ 525 (6.1%)Bira ₹ 108 (0%)CIAL ₹ 438 (0%)CSK ₹ 266 (3.1%)ESDS Software₹ 448 (0.7%)Garuda Aerospace₹ 485 (0%)GFCL EV₹ 42 (0%)Hero Fincorp₹ 1075 (2.4%)HPX India₹ 28 (7.7%)Incred Holdings₹ 150 (1.4%)India Carbon₹ 895 (0%)Indian Potash₹ 2850 (3.6%)Inox Clean₹ 725 (-8.8%)Insolare Energy₹ 185 (0%)Lava ₹ 52 (8.3%)Matrix Gas₹ 16 (0%)Motilal Oswal₹ 12.95 (12.6%)MSEI ₹ 6.25 (-3.8%)NCDEX ₹ 388 (-4.2%)NeRL ₹ 58 (0%)NSE ₹ 1975 (2.6%)Onix Renewable₹ 66 (13.8%)Orbis Financial₹ 408 (0.7%)OYO ₹ 24 (0%)Pharmeasy ₹ 6.25 (-3.8%)Polymatech Electronics₹ 62 (-3.1%)RRP S4E₹ 168 (0%)SBI Mutual₹ 775 (0%)Ticker Ltd₹ 32 (0%)Zepto ₹ 49 (-9.3%)

15 Days Price Change

Dhansa Labs IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 1985 Industry: Pesticides & Agrochemicals Listed Page

Profile
Issue Size --
Profile
Price Range 65  to  68 per share
Profile
Min Investment ₹68
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Ambey Group is a conglomerate of companies with interest in sectors such as FMCG, Agrochemicals and Cement. Founded in 1977, the India based group is a fast growing and accomplished provider of products across these industries, offering renowned brands such as Anya, A10 and others. The brand has global footprints, with strong presence in Middle East, Africa, Asia Pacific, South Asia and Eastern Europe regions. The group is inspired relentlessly by a vision of ‘Globalizing and Diversifying Towards Higher Wealth Creation’ and has registered strong growth across business segments and geographies in this endeavour to become a reputed name in the International arena. Read More

Basic Info

Face Value 10 per share

Price 65  to  68 per share

P/E (x) 32.4

Sales( Cr.) 131

PAT( Cr.) 5

EPS 2.1

Draft Prospectus --

Exchange NSE-SME

Promoter

Company Promoters

Archit Gupta Arpit Gupta Sarina Gupta Rishita Gupta.

Pre Issue Share Holding 94.97%

Post Issue Share Holding --%

Listing Details:

Listing Price: 85

Listing Gain: 20%

Current Price: 31.5

Gain On Issue: 31.5 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jul 04, 2024
Closing Date Jul 08, 2024
Allotment Jul 09, 2024
Refund Jul 10, 2024
Delivery of Shares Jul 10, 2024
Listing Date Jul 11, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 136,000
Retail (Max) 1 2000 136,000
S-HNI (Min) 2 4000 272,000
S-HNI (Max) 7 14000 952,000
B-HNI (Min) 8 16000 1,088,000

Objective of the Issue

1.To meet Working Capital Requirements 2. General corporate purposes 3. Issue related expenses

Issue

Category Nos Bid Bid (x)
QIB 3285000 203341500 61.9x
NII 985500 319518810 324.2x
Retail 2299500 448540470 195.1x
EMP 0 0 0x
Total 6570000 1137792600 173.2x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Dhansa Labs Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 82 85 105 120 131
Other Income 1 1 3 2 2
Total Income 82 85 108 122 133
Total Expenditure 72 74 97 111 122
Operating Profit 10 11 11 11 12
Interest 4 3 2 2 3
Depreciation 3 3 3 3 3
Exceptional Income / Expenses 0 0 -0 -0 0
Profit Before Tax 3 5 6 5 6
Provision for Tax -7 1 0 -2 1
Profit After Tax 10 4 5 8 5
Adjustments 0 0 0 0 0
Profit After Adjustments 10 4 5 8 5
Adjusted Earnings Per Share 21.1 2 3 4.1 1.9

Dhansa Labs Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -8 19 19 32 76
Minority's Interest 0 0 0 0 0
Borrowings 30 14 13 16 11
Other Non-Current Liabilities -6 -5 -0 -2 -1
Total Current Liabilities 22 22 22 31 40
Total Liabilities 37 50 54 77 126
Fixed Assets 16 25 25 24 23
Other Non-Current Assets 1 0 0 4 16
Total Current Assets 20 24 28 48 87
Total Assets 37 50 54 77 126

Dhansa Labs Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 0 0 0
Cash Flow from Operating Activities 3 6 10 -13 -34
Cash Flow from Investing Activities -1 -1 -4 -5 -13
Cash Flow from Financing Activities -1 -5 -6 18 48
Net Cash Inflow / Outflow 0 -0 0 -0 0
Closing Cash & Cash Equivalent 1 0 0 0 1

Dhansa Labs Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 21.12 2.01 2.95 4.13 1.92
CEPS(Rs) 27.71 3.69 4.62 5.48 2.94
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) -16.07 10.74 4.87 11.24 26.4
Core EBITDA Margin(%) 11.92 12.23 7.49 7.54 7.33
EBIT Margin(%) 8.81 9.33 7.24 6.52 6.85
Pre Tax Margin(%) 3.78 5.71 5.25 4.51 4.6
PAT Margin (%) 12.65 4.23 5 6.41 3.64
Cash Profit Margin (%) 16.59 7.74 7.83 8.5 5.58
ROA(%) 27.64 8.18 10.12 11.85 4.72
ROE(%) 0 63.82 37.82 52.08 11.01
ROCE(%) 28.72 25.38 25.37 21.4 11.43
Receivable days 31.11 33.42 21.05 33.71 82.19
Inventory Days 38.99 42.03 48.53 57.1 70.19
Payable days 89.08 82.3 62.59 53.06 33.43
PER(x) 0 0 0 0 20.97
Price/Book(x) 0 0 0 0 1.52
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.46 0.42 0.3 0.4 1.06
EV/Core EBITDA(x) 3.58 3.27 2.96 4.49 12.08
Net Sales Growth(%) 0 3.5 23.9 14.93 8.96
EBIT Growth(%) 0 9.62 -3.77 3.45 14.44
PAT Growth(%) 0 -65.42 46.59 47.36 -38.06
EPS Growth(%) 0 -90.47 46.58 39.95 -53.6
Debt/Equity(x) -4.19 0.95 1.63 1.41 0.62
Current Ratio(x) 0.92 1.13 1.29 1.56 2.19
Quick Ratio(x) 0.52 0.63 0.51 0.9 1.43
Interest Cover(x) 1.75 2.58 3.63 3.24 3.05
Total Debt/Mcap(x) 0 0 0 0 0.41

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 16% 0% 0%
Operating Profit CAGR 9% 3% 0% 0%
PAT CAGR -38% 8% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -17% NA% NA% NA%
ROE Average 11% 34% 33% 33%
ROCE Average 11% 19% 22% 22%

Company Contact Information

Dhansa Labs Ltd.

Ground Floor, Property No.555 Tarla Mohalla, Ghitorni South West Delhi

IPO Lead Manager(s)

Dhansa Labs Ltd.

Fast Track Finsec Pvt Ltd.

Registrar Info

Dhansa Labs Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!